Verified· 2 sources

Tigen Pharma SA

Summary

About the company

The core activity of Tigen Pharma is the development and acceleration of access to new therapies in the field of cell and gene therapy, particularly for the treatment of cancer. The company combines scientific expertise, technological capabilities and a long-term perspective to develop innovative solutions for patients and society.

AI-generated

Offering

Products & services

Industry:Pharmaceutical Industry

✓ Offered4

Cell and Gene Therapies

Cell and gene therapies for cancer, focusing on autologous T-cell–based therapies for solid and liquid tumors as well as on a Phase I development for r/r AML.

Development of Therapies for Cell and Gene Therapy

Development of new therapies from idea through proof of concept to confirmation of efficacy, including scientific development from research through to clinical application.

Cell and Gene Therapy Manufacturing Platform

Standardized and versatile manufacturing platform for patient-centric on-demand and on-time production, with GMP-oriented processes and support from research through to a commercial setting.

Partnerships for Commercialization and Patient Access

Partnerships with academic, regional and global institutions to translate research, develop through to commercialization, and enable market and patient access.

Outbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub

Tigen Pharma SA

About the company

Products & services

Looking for direct email addresses and phone numbers?

Tigen Pharma SA

About the company

Products & services

Looking for direct email addresses and phone numbers?

No knowledge articles yet

Tigen Pharma SA in comparison

Industry comparisons are coming soon

Similar companies